WallStSmart

Everus Construction Group Inc (ECG)vsMasTec Inc (MTZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MasTec Inc generates 282% more annual revenue ($14.30B vs $3.75B). ECG leads profitability with a 5.4% profit margin vs 2.8%. ECG trades at a lower P/E of 30.6x. ECG earns a higher WallStSmart Score of 61/100 (C+).

ECG

Buy

61

out of 100

Grade: C+

Growth: 9.3Profit: 7.0Value: 8.3Quality: 8.0
Piotroski: 4/9Altman Z: 4.64

MTZ

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 5.5Value: 5.3Quality: 7.0
Piotroski: 4/9Altman Z: 2.59
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ECGUndervalued (+44.5%)

Margin of Safety

+44.5%

Fair Value

$184.86

Current Price

$123.29

$61.57 discount

UndervaluedFair: $184.86Overvalued
MTZOvervalued (-7.7%)

Margin of Safety

-7.7%

Fair Value

$246.17

Current Price

$323.55

$77.38 premium

UndervaluedFair: $246.17Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ECG5 strengths · Avg: 9.8/10
Return on EquityProfitability
38.3%10/10

Every $100 of equity generates 38 in profit

Revenue GrowthGrowth
33.2%10/10

Revenue surging 33.2% year-over-year

EPS GrowthGrowth
60.2%10/10

Earnings expanding 60.2% YoY

Altman Z-ScoreHealth
4.6410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

MTZ2 strengths · Avg: 9.0/10
EPS GrowthGrowth
92.8%10/10

Earnings expanding 92.8% YoY

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

Areas to Watch

ECG3 concerns · Avg: 3.7/10
P/E RatioValuation
30.6x4/10

Premium valuation, high expectations priced in

Price/BookValuation
10.0x4/10

Trading at 10.0x book value

Profit MarginProfitability
5.4%3/10

5.4% margin — thin

MTZ3 concerns · Avg: 3.0/10
PEG RatioValuation
1.964/10

Expensive relative to growth rate

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

P/E RatioValuation
61.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : ECG

The strongest argument for ECG centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 33.2% demonstrates continued momentum.

Bull Case : MTZ

The strongest argument for MTZ centers on EPS Growth, Revenue Growth. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : ECG

The primary concerns for ECG are P/E Ratio, Price/Book, Profit Margin.

Bear Case : MTZ

The primary concerns for MTZ are PEG Ratio, Profit Margin, P/E Ratio. A P/E of 61.3x leaves little room for execution misses. Thin 2.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

ECG profiles as a hypergrowth stock while MTZ is a growth play — different risk/reward profiles.

ECG is growing revenue faster at 33.2% — sustainability is the question.

MTZ generates stronger free cash flow (214M), providing more financial flexibility.

Monitor ENGINEERING & CONSTRUCTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ECG scores higher overall (61/100 vs 58/100) and 33.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Everus Construction Group Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Everus Construction Group, Inc. provides utility construction services. The company is headquartered in Bismarck, North Dakota.

Visit Website →

MasTec Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

MasTec, Inc., an infrastructure construction company, provides engineering, construction, installation, maintenance, and upgrade services for communications, energy, utilities, and other infrastructure primarily in the United States and Canada. The company is headquartered in Coral Gables, Florida.

Visit Website →

Want to dig deeper into these stocks?